Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
Pharma
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel.   5 June 2025
Ukraine law change means rightsholders need to prepare
Europe
Ukraine law change means rightsholders need to prepare
A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a patent expires, explains Volodymyr Hrunskyi of Sayenko Kharenko.   3 June 2025
Weight-loss clinic hits back at Novo Nordisk’s Ozempic TM allegations
Americas
Weight-loss clinic hits back at Novo Nordisk’s Ozempic TM allegations
Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo Nordisk products in past marketing but it has since been removed | Clinic claims its compounded semaglutide use was lawful and clear to patients.   29 May 2025
Americas
Eisai and Merck shield blockbuster cancer drug from generic challenge
Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s product off the market until 2036.   29 May 2025
Americas
Fed Circ refuses to stay Novartis feud with MSN over Entresto
Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic company hoped to stay proceedings to prepare appeal against unfavourable decision.   27 May 2025
Europe
Moderna entities must face infringement suits, UPC rules
UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories.   27 May 2025
Europe
As AI shakes up pharma and biotech, can patent law keep up?
Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis.   22 May 2025
Europe
UK court clears the way for Amgen and Samsung to launch biosimilars
AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent.   22 May 2025
Americas
SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute
South Korean company eyes new business opportunities following Supreme Court ruling | Pfizer had claimed infringement of patent covering Prevenar 13 shot.   22 May 2025
Americas
Sanofi unit loses genetic disorder patent at EPO after trio of challenges
Boards of Appeal revokes Genzyme patent, handing win to Accord Healthcare | Teva and Hetero Labs also previously filed oppositions | Patent refers to Cerdelga, part of Sanofi’s Gaucher disease franchise.   20 May 2025